Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

RadNet, Inc.(RDNT US)

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees
Logo
RDNT US​

RadNet, Inc. — Company Profile

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UQ
CEO
Howard G. Berger
Headquarters
Los Angeles, CA, US
IPO Date
Jan 3, 1997
Employees
9,060
Website
www.radnet.com

Key Metrics

Price
$69.93
Market Cap
$5.50B
Revenue (TTM)
$575.63M
Net Income (TTM)
$-33466000.00
EPS (TTM)
-0.43
P/E (TTM)
-387.46
P/B (TTM)
5.09
Dividend Yield
0.00%
ROE (TTM)
-3.10%
ROA (TTM)
-0.86%
Operating Margin
-2.85%
Beta
0.98

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Website
www.radnet.com
Location
Los Angeles, CA, US
Phone310 478 7808
Employees9,060
CEOHoward G. Berger
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateJan 3, 1997

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.

Latest Documents

SEC Filings(1.3K)

Expand
  • 8-KOther Events14 Aug
  • 424B7PROSPECTUS14 Aug
  • SC 13G/ARadNet, Inc.14 Aug
  • 10-QQ2ended 30 Jun 202610 Aug
  • 8-KPRESS RELEASE DATED AUGUST 9, 202610 Aug
  • 4SWARTZ DAVID L22 Jun
  • 4Wesdorp Cornelis18 Jun
  • 4Berger Howard G18 Jun
  • 144SWARTZ DAVID L18 Jun
  • 144Wesdorp Cornelis16 Jun
  • 4Forthuber Stephen M16 Jun
  • 144Forthuber Stephen M15 Jun
  • 8-KPRESS RELEASE DATED JUNE 10, 202610 Jun
  • 4SWARTZ DAVID L3 Jun
  • 4SPURLOCK GREGORY E.3 Jun
  • 4Jacobs Laura Pastre3 Jun
  • 4Levitt Lawrence L3 Jun
  • 8-KSubmission of Matters to a Vote of Security Holders3 Jun
  • 8-KPRESS RELEASE3 Jun
  • SC 13GRadNet, Inc.15 May

News

  • Head-To-Head Review: RadNet (NASDAQ:RDNT) vs. Joint (NASDAQ:JYNT)22 Oct
  • New Study Shows DeepHealth AI Could Help Avoid Nearly One in Five Prostate Biopsies8 Oct
  • RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals1 Oct
  • Engineers Gate Manager LP Acquires New Holdings in RadNet, Inc. $RDNT24 Sep
  • RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript16 Sep
  • RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 20269 Sep
  • RadNet to Host Free Prostate Cancer Webinar on September 19, 20269 Sep
  • RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 20268 Sep
  • Bamco Inc. NY Invests $77.77 Million in RadNet, Inc. $RDNT27 Aug
  • Head to Head Contrast: RadNet (NASDAQ:RDNT) and Oncology Institute (NASDAQ:TOI)24 Aug
  • RadNet: Imaging And AI Keep The Bull Case Intact12 Aug
  • RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance Raised11 Aug
  • RadNet (NASDAQ:RDNT) Trading Up 6.9% on Earnings Beat11 Aug
  • RadNet, Inc. (RDNT) Q2 2026 Earnings Call Transcript10 Aug
  • RadNet Q2 Earnings Call Highlights10 Aug
  • RadNet Reports Strong Q2 Results, Boosting Investor Confidence10 Aug
  • RadNet (RDNT) Reports Q2 Earnings: What Key Metrics Have to Say10 Aug
  • RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges9 Aug
  • Countdown to RadNet (RDNT) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS6 Aug
  • DeepHealth Receives FDA Clearance for AI-Powered Breast Ultrasound30 Jul

Mentions in Filings

  • … er the Exchange Act can be located by reference to its SEC file number: 001-13202, or its CIK Code: 0000924613. Its American depositary receipts are listed on the New York Stock Exchange under the ticker symbol “NOK.” <strong>RadNet, Inc.</strong> is a diagnostic imaging services company. Information filed by the company with the SEC under the Exchange Act can be located by reference to its SEC file number: 001-33307, or its CIK Code: 0000790526. Its common stoc …
    BANK OF MONTREAL /CAN/RadNet, Inc.·FWP - ELN 6351·Q4 26·6 Oct
  • … 3 \*PTC Therapeutics, Inc. 12,771 964,594 \*Puma Biotechnology, Inc. 15,090 97,783 \* Quanterix Corp. 6,044 38,319 Quest Diagnostics, Inc. 31,894 5,965,135 \* QuidelOrtho Corp. 18,497 502,563 \* <strong>RadNet</strong> , Inc. 18,856 1,321,806 \*Rafael Holdings, Inc., Class B 922 1,070 \*Rapport Therapeutics, Inc. 397 10,564 Regeneron Pharmaceuticals, Inc. 29,575 21,928,384 \*REGENXBIO, Inc. 20,910 233,356 \*Rel …
    Dimensional ETF TrustRadNet, Inc.·NPORT-EX - NT NPORT-P - Notification of late filing (portfolio holdings)·Q1 26·13 Aug
  • … enue to continue as we bring on more insurance payors, and our scan volumes increase. *Cost of Revenue*. Direct cost of revenue is comprised of hosting and software costs, field support, UCSF royalty cost, partner fees (<strong>Radnet</strong>), and credit card fees. Total cost of revenue was $16,911 for the three months ended June 30, 2026, compared to $14,179 for the same period ended June 30, 2025, an increase of $2,732 or 19.3%. The increase was primarily a …
    Aclarion, Inc.RadNet, Inc.·10-Q - Quarterly report Q2·Q2 26·6 Aug
  • … gs, Inc. | Glaukos Corporation | Nevro Corp. | | AngioDynamics, Inc. | Inari Medical, Inc. | Orthofix Medical Inc. | | AtriCure, Inc. | Inogen, Inc. | Penumbra, Inc. | | Artivion, Inc. | Inspire Medical Systems, Inc. | <strong>RadNet, Inc.</strong> | | Avanos Medical, Inc. | iRhythm Technologies, Inc. | Tactile Systems Technology, Inc. | | CONMED Corporation | Lantheus Holdings, Inc. | Tandem Diabetes Care, Inc. | | Cutera, Inc. | Merit Medical Systems, Inc. | Va …
    ACCURAY INCRadNet, Inc.·DEF 14A - Definitive proxy statement·Q2 27·16 Oct
  • … he common stock of DexCom, Inc. | DXCM | 6.66% | | | | The common stock of Intuitive Surgical, Inc. | ISRG | 6.66% | | | | The American depositary receipts of Nokia Corporation | NOK | 6.66% | | | | The common stock of <strong>RadNet, Inc.</strong> | RDNT | 6.66% | | | | The common stock of Rocket Lab Corporation | RKLB | 6.66% | | | | The Class A common stock of Ralph Lauren Corporation | RL | 6.66% | | | | The ordinary shares of Spotify Technology S.A. | SPOT | …
    BANK OF MONTREAL /CAN/RadNet, Inc.·FWP - ELN 6352·Q4 26·6 Oct
  • … nsultants | 1,000 | 5,650.000 | 5,650,000 | | | | | Japan - Yen Subtotal | 38,800 | | 2,047,328,750 | | | US Dollar | CLARIVATE PLC | 11,114 | 2.040 | 22,672.56 | | | GENIUS SPORTS LTD | 12,675 | 6.100 | 77,317.50 | | | | <strong>RADNET</strong> INC | 3,777 | 53.740 | 202,975.98 | | | | BOX INC - CLASS A | 7,183 | 24.840 | 178,425.72 | | | | CELLEBRITE DI LTD | 6,665 | 12.830 | 85,511.95 | | | | COGNYTE SOFTWARE LTD | 3,794 | 8.320 | 31,566.08 | | | | COREWEAVE I …
    三井住友DSアセットマネジメント株式会社RadNet, Inc.·Annual Report - Annual Securities Report (2025.06.21-2026.06.22)·17 Sep·16 Sep

Key Stats

Trading

Px/Chg 1D$69.93 / +3.29%
Avg Volume885.37K
Beta0.98
Mkt Cap5.50B
FD Mkt Cap5.90B

Float

Shrs Out/Float78.63M / 70.36M
Short Float0.14%
Days to Cover7.89
Stock Repurchased$0.00

Current Valuation

EV7.25B
EV/EBITDA22.38
EV/Sales3.38
P/B5.09
P/S2.56
FCF Yield0.41%
ROE-3.10%
ROA-0.86%
Current Ratio1.17

Estimates

P/E-387.46
Est P/EN/A
Est EPSN/A
Est PEGN/A

Valuation

Metric5Yr AvgMay '23May '24May '25May '26Oct '26
PRICE-BASED RATIOS
Price / Earnings-953.13150.961,118.921,457.61-7,328.81-164.31
Price / Sales4.601.122.112.237.999.55
Price / Book Value4.774.835.404.514.015.09
Price / Free Cash Flow75.82-15.6176.9590.56-18.95246.16
ENTERPRISE VALUE METRICS
Enterprise Value5,232.63,151.84,737.25,291.05,732.97,250.1
Enterprise Value / Sales6.222.202.932.8910.4712.59
Enterprise Value / EBITDA66.4011.3216.1820.1541.02243.32
Enterprise Value / EBIT-41.8433.6045.8642.43146.83-477.89

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '21Dec '22Dec '23Dec '24Dec '25
INCOME STATEMENT
Revenue11.6%1,315.11,430.11,616.61,829.72,040.2
Gross Income-17.1%191.8165.7221.4249.190.8
EBITDA-2.3%278.4278.5292.8262.5253.9
EBIT-1.4%107.793.8103.3124.7101.8
Net Income—24.710.73.02.8-18.7
EPS (Diluted)—0.460.170.050.04-0.25
BALANCE SHEET
Cash & ST Inv54.5%134.6127.8342.6740.0767.2
Total Assets16.2%2,058.52,433.92,690.53,286.73,758.6
Total Liabilities8.8%1,712.31,942.51,877.12,153.32,402.7
Total Shareholder Equity47.7%228.9333.0630.7902.31,089.9
CASH FLOW
Net Operating Cash Flow18.9%149.5146.4220.9233.0298.8
Cap Ex-85.4%-220.7-249.4-176.6-188.1-213.3
Free Cash Flow—-71.2-103.044.345.085.6

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)70.44
Basic Shares78.63
Market Cap5,539.0
Diluted Shares77.06
Fully Diluted Shares Outstanding77.06
Fully Diluted Market Cap5,428.0
+Consolidated Debt1,934.4
−In-the-Money Convertible Debt—
+Capital Leases847.9
+Operating Leases—
−Cash & Equivalents-455.3
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest272.2
+Pension Liabilities—
Enterprise Value7,290.2

Segment data

Revenue

by Products and services

  • Commercial Insurance159%
  • Medicare125%
  • Capitation Arrangements7%
  • Health Care, Other3%
  • Medicaid13%

Revenue

by Geography

  • United States98%
  • Non-us2%

Related companies

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Labcorp Holdings Inc.

LH US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

Sotera Health Co

SHC US

Vontier Corp

VNT US

DiaSorin S.p.A.

DSRLF US